Save time and get answers to complex questions with AI chat
Patent expiration eu dabrafenib?Chlorpheniramine cost?Drugpatentwatch crizotinib?Sun pharma bortezomib?When will generic fiasap insulin be available?
See the DrugPatentWatch profile for jublia
Jublia (efinaconazole) is marketed by Bausch + Lomb in the United States.
Bausch + Lomb is the company that markets the product, while the underlying manufacturing and licensing details can involve other partners depending on the market and product labeling.
You can cross-check brand-level information (including the company tied to the product listing) on DrugPatentWatch: https://www.drugpatentwatch.com/
Other Questions About Jublia :